Approval · Notice of Compliance 5248 · 1995
GEREF: Notice of Compliance 5248
Issued June 8, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5248
- Date
- June 8, 1995
- Company
- Serono Canada Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Diagnostic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEREF | 02168502 | — |
Medicinal ingredients
- SERMORELIN ACETATE 50 MCG per AMP